CONSENT TO ASSIGNMENT AND FIRST AMENDMENT TO LEASESigilon Therapeutics, Inc. • November 13th, 2020 • Pharmaceutical preparations
Company FiledNovember 13th, 2020 IndustryThis Consent to Assignment and First Amendment to Lease (this “Consent”) is made as of October 21, 2019, between and among ARE-MA REGION NO. 45, LLC, a Delaware limited liability company (“Landlord”), FOGHORN THERAPEUTICS INC., a Delaware corporation (“Tenant”), and SIGILON THERAPEUTICS, INC., a Delaware corporation (“Assignee”), with reference to the following Recitals.
CONSENT TO ASSIGNMENT AND FIRST AMENDMENT TO LEASESigilon Therapeutics, Inc. • October 30th, 2020 • Pharmaceutical preparations
Company FiledOctober 30th, 2020 IndustryThis Consent to Assignment and First Amendment to Lease (this “Consent”) is made as of October 21, 2019, between and among ARE-MA REGION NO. 45, LLC, a Delaware limited liability company (“Landlord”), FOGHORN THERAPEUTICS INC., a Delaware corporation (“Tenant”), and SIGILON THERAPEUTICS, INC., a Delaware corporation (“Assignee”), with reference to the following Recitals.